The current drug development research paradigm is flawed in that it fails to include a diverse and representative patient population. A new approach that begins with a patient-centric mindset, coupled with the use of mobile technology and connected health platforms, will enable research to become less reliant on site-based visits and bring equal access to new investigational therapies for all patients, regardless of geography, ethnicity, sex, or gender.
In this white paper, you will learn about:
- The current diversity gap and limitations in clinical research
- Barriers for underrepresented patient populations
- Breaking barriers with patient-centric approaches and advanced technology
- Foundations for a new clinical research model
- Engaging and protecting patients with technology
Explore related content and topics
Blog
Legal and Regulatory Considerations to Implement Decentralized Clinical Trials
With Decentralized Clinical Trials (DCTs) becoming more prevalent, so have the initiatives, recommendations, and regulations. Read about what to…
Blog
Geriatric Drug Development Challenges and Strategies for Success
As the global population continues to age, the need for geriatric and elderly participants in clinical trials increases. Read on to learn how drug…
Blog
The Benefits of Home Health Care in Pediatric Clinical Trials
Home health care has long been utilized in clinical trials. With the increased interest in adopting clinical trial models like decentralized clinical…